119 related articles for article (PubMed ID: 2575496)
1. Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen.
Cunningham ML; Burka LT; Matthews HB
Drug Metab Dispos; 1989; 17(6):612-7. PubMed ID: 2575496
[TBL] [Abstract][Full Text] [Related]
2. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
Ress NB;
Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
[TBL] [Abstract][Full Text] [Related]
3. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
Timchalk C; Smith FA; Bartels MJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
[TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an acetoxyarylamine as the ultimate mutagenic reactive intermediate of the carcinogenic aromatic amine 2,4-diaminotoluene.
Cunningham ML; Matthews HB
Mutat Res; 1990 Oct; 242(2):101-10. PubMed ID: 2233826
[TBL] [Abstract][Full Text] [Related]
6. Effect of microsomal enzyme inducers on the urinary excretion pattern of mutagenic metabolites of the carcinogen 2,4-toluenediamine.
Reddy TV; Ramanathan R; Benjamin T; Grantham PH; Weisburger EK
J Natl Cancer Inst; 1986 Feb; 76(2):291-7. PubMed ID: 3456067
[TBL] [Abstract][Full Text] [Related]
7. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
8. Metabolism, distribution, and excretion of the carcinogenic aromatic amine, 3,3'-dimethoxybenzidine in the rat. Formation of mutagenic urinary and biliary metabolites.
Rodgers RM; Garvie-Gould C; Scott KF; Milam DF; Lynn RK
Drug Metab Dispos; 1983; 11(4):293-300. PubMed ID: 6137333
[TBL] [Abstract][Full Text] [Related]
9. Mutagenic metabolites in urine and feces of rats fed with 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, a carcinogenic mutagen present in cooked meat.
Hayatsu H; Kasai H; Yokoyama S; Miyazawa T; Yamaizumi Z; Sato S; Nishimura S; Arimoto S; Hayatsu T; Ohara Y
Cancer Res; 1987 Feb; 47(3):791-4. PubMed ID: 3542193
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin H synthase-dependent genotoxicity of 2,4-diaminotoluene.
Pan YH; Reddy GR; Reed GA
Environ Mol Mutagen; 1992; 19(3):201-8. PubMed ID: 1572343
[TBL] [Abstract][Full Text] [Related]
11. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
12. In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N'-diacetyl metabolites.
Garrigue JL; Ballantyne M; Kumaravel T; Lloyd M; Nohynek GJ; Kirkland D; Toutain H
Mutat Res; 2006 Sep; 608(1):58-71. PubMed ID: 16807077
[TBL] [Abstract][Full Text] [Related]
13. The interaction of methanol, rat-liver S9 and the aromatic amine 2,4-diaminotoluene produces a new mutagenic compound.
Cunningham ML; Burka LT; Matthews HB
Mutat Res; 1990 Aug; 244(4):273-7. PubMed ID: 2385242
[TBL] [Abstract][Full Text] [Related]
14. 1,2-dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene.
Hecht SS; LaVoie E; Mazzarese R; Amin S; Bedenko V; Hoffmann D
Cancer Res; 1978 Jul; 38(7):2191-4. PubMed ID: 350385
[TBL] [Abstract][Full Text] [Related]
15. Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair--2,6- and 2,4-diaminotoluene.
Cunningham ML; Foley J; Maronpot RR; Matthews HB
Toxicol Appl Pharmacol; 1991 Mar; 107(3):562-7. PubMed ID: 2000642
[TBL] [Abstract][Full Text] [Related]
16. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
Cunningham ML; Hayward JJ; Shane BS; Tindall KR
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and genotoxic interactions of 2-aminofluorene and 2,4-diaminotoluene.
Pan YH; Reed GA
Toxicol Lett; 1997 Mar; 91(1):73-82. PubMed ID: 9096289
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the metabolism of 2,4-toluenediamine in rats and mice.
Grantham PH; Mohan L; Benjamin T; Roller PP; Miller JR; Weisburger EK
J Environ Pathol Toxicol; 1979 Dec; 3(1-2):149-66. PubMed ID: 547012
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
20. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
